Thioridazine and severe cardiac arrhythmia.
Thioridazine prolongs the QT interval and carries a risk of torsades de pointes. Several cases of syncope, cardiovascular collapse and sudden death have been published.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D000075202:Contraindications; D004347:Drug Interactions; D005602:France; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000008:administration & dosage / Q000009:adverse effects*; D016171:Torsades de Pointes / Q000139:chemically induced; D006113:United Kingdom; D014481:United States
D014150:Antipsychotic Agents; D013881:Thioridazine